Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musa

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern AfricaLuka Verrest, Anke E Kip, Ahmed M Musa, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 18, 2025
Comparative Cost Analysis for Direct Medical Costs of Protocol Administration of Non-Small Cell Lung Cancer Treatment Regimens in Curative Intent: A Micro-Costing Study in JordanSaba S Madae'en, Ahmed A Salem, Naila S Ararawi, et al.
Japanese Journal of Infectious Diseases|September 23, 2008
Genetic characterization of Staphylococcus aureus isolates carrying Panton-Valentine leukocidin genes in BangladeshSadia Afroz, Nobumichi Kobayashi, Shigeo Nagashima, et al.
Trials|June 12, 2019
Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study designMuktar H Aliyu, Usman J Wudil, Donna J Ingles, et al.
Nigerian Journal of Clinical Practice|June 4, 2026
Association Between L-Arginine Levels and Microalbuminuria in Sickle Cell Disease: A Cross-Sectional Study in a Tertiary Hospital in Northwest NigeriaD H Gwarzo, A Kuliya-Gwarzo, A A Yusuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanBrima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
The Journal of Infectious Diseases|July 12, 2011
Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27Michaela Fakiola, E Nancy Miller, Manal Fadl, et al.
Plos Neglected Tropical Diseases|January 24, 2014
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, et al.
Implementation Science Communications|August 27, 2021
The CircumVent Project: a CPAP/O<sub>2</sub> helmet solution for non-invasive ventilation using an implementation research frameworkAimalohi A Ahonkhai, Adesola Z Musa, André A Fenton, et al.
BMJ Global Health|August 5, 2025
Cost-effectiveness of different tuberculosis diagnostic approaches in Nigeria based on decision analytical modellingHafsat U Ibrahim, Rayyan M Garba, Jameel I Ahmad, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern AfricaLuka Verrest, Anke E Kip, Ahmed M Musa, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 18, 2025
Comparative Cost Analysis for Direct Medical Costs of Protocol Administration of Non-Small Cell Lung Cancer Treatment Regimens in Curative Intent: A Micro-Costing Study in JordanSaba S Madae'en, Ahmed A Salem, Naila S Ararawi, et al.
Japanese Journal of Infectious Diseases|September 23, 2008
Genetic characterization of Staphylococcus aureus isolates carrying Panton-Valentine leukocidin genes in BangladeshSadia Afroz, Nobumichi Kobayashi, Shigeo Nagashima, et al.
Trials|June 12, 2019
Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study designMuktar H Aliyu, Usman J Wudil, Donna J Ingles, et al.
Nigerian Journal of Clinical Practice|June 4, 2026
Association Between L-Arginine Levels and Microalbuminuria in Sickle Cell Disease: A Cross-Sectional Study in a Tertiary Hospital in Northwest NigeriaD H Gwarzo, A Kuliya-Gwarzo, A A Yusuf, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanBrima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
The Journal of Infectious Diseases|July 12, 2011
Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27Michaela Fakiola, E Nancy Miller, Manal Fadl, et al.
Plos Neglected Tropical Diseases|January 24, 2014
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, et al.
Implementation Science Communications|August 27, 2021
The CircumVent Project: a CPAP/O<sub>2</sub> helmet solution for non-invasive ventilation using an implementation research frameworkAimalohi A Ahonkhai, Adesola Z Musa, André A Fenton, et al.
BMJ Global Health|August 5, 2025
Cost-effectiveness of different tuberculosis diagnostic approaches in Nigeria based on decision analytical modellingHafsat U Ibrahim, Rayyan M Garba, Jameel I Ahmad, et al.
Pageof 26